A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Cervical Cancer
Related studies linked through entity extraction aliases.
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Proton and Carbon Ion Radiotherapy for Cervical Cancer
- Status
- COMPLETED
- Phase
- NA
AK105 Combined With Anlotinib in Patients With Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Strategies to Improve the Experience of Gynaecological Screening
- Status
- COMPLETED
- Phase
- NA
Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia
- Status
- RECRUITING
- Phase
- NA
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- PHASE1
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
- Status
- COMPLETED
- Phase
- NA
A Study of DeTIL-0255 in Adults With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of NX-1607 in Adults With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Asian Multicenter Prospective Study of ctDNA Sequencing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
- Status
- RECRUITING
- Phase
- PHASE1
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
- Status
- RECRUITING
- Phase
- PHASE3
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Early Ageing During Therapy in AYA Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Human Papilloma Virus (HPV) Self-collection and Women Adherence
- Status
- UNKNOWN
- Phase
- NA